<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://tpx.sagepub.com">
<title>Toxicologic Pathology current issue</title>
<link>http://tpx.sagepub.com</link>
<description>Toxicologic Pathology RSS feed -- current issue</description>
<prism:coverDisplayDate>October 2009</prism:coverDisplayDate>
<prism:publicationName>Toxicologic Pathology</prism:publicationName>
<prism:issn>0192-6233</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/37/6/705?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/708?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/714?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/733?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/741?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/754?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/761?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/770?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/776?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/790?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/799?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/805?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/814?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/content/abstract/37/6/819?rss=1" />
  <rdf:li rdf:resource="http://tpx.sagepub.com/cgi/reprint/37/6/826?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://tpx.sagepub.com:80/icons/banner/title.gif" />
</channel>

<image rdf:about="http://tpx.sagepub.com:80/icons/banner/title.gif">
<title>Toxicologic Pathology</title>
<url>http://tpx.sagepub.com:80/icons/banner/title.gif</url>
<link>http://tpx.sagepub.com</link>
</image>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/37/6/705?rss=1">
<title><![CDATA[The Role of the Toxicologic Pathologist in Risk Management]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/37/6/705?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ochoa, R., Rousseaux, C.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309344434</dc:identifier>
<dc:title><![CDATA[The Role of the Toxicologic Pathologist in Risk Management]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>707</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>705</prism:startingPage>
<prism:section>Guest Editorial</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/708?rss=1">
<title><![CDATA[Emanuel Edward Klein--The Father of British Microbiology and the Case of the Animal Vivisection Controversy of 1875]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/708?rss=1</link>
<description><![CDATA[
<p>The new Appendix A of the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, which gives guidelines for accommodation and care of animals and was approved on June 15, 2006, was the main reason the authors decided to investigate the origins of the regulations of animal experiments. Although one might assume that the regulation had its origin in the United Nations conventions, the truth is that its origins are a hundred years old. The authors present a case of the nineteenth-century vivisection controversy brought about by the publication of the <I>Handbook for the Physiological Laboratory</I> in 1873, in which John Burdon-Sanderson, Emanuel Edward Klein, Michael Foster, and Thomas Lauder Brunton described a series of vivisection experiments they performed on animals for research purposes. It was the first case of vivisection to be examined, processed, and condemned for inhuman behavior toward animals before an official body, leading to enactment of the Cruelty to Animals Act in 1876. The case reveals a specific ethos of science in the second half of the nineteenth century, which was characterized by a deep commitment of scientists to the scientific enterprise and their strong belief that science could solve social problems, combined with an overt insensitivity to the suffering of experimental animals. The central figure in the case was Emanuel Edward Klein, a disciple of the Central European medical tradition (Vienna Medical School) and a direct follower of the experimental school of Br&uuml;cke, Stricker, Magendie, and Bernard. Because of his undisguised attitudes and opinions on the use of vivisection, Klein became a paradigm of the new scientific identity, strongly influencing the stereotypic image of a scientist, and polarizing the public opinion on vivisection in England in the nineteenth century and for some considerable time afterward.</p>
]]></description>
<dc:creator><![CDATA[Atalic, B., Fatovic-Ferencic, S.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309345871</dc:identifier>
<dc:title><![CDATA[Emanuel Edward Klein--The Father of British Microbiology and the Case of the Animal Vivisection Controversy of 1875]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>713</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>708</prism:startingPage>
<prism:section>Historical Reviews</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/714?rss=1">
<title><![CDATA[A Data-Based Assessment of Alternative Strategies for Identification of Potential Human Cancer Hazards]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/714?rss=1</link>
<description><![CDATA[
<p>The two-year cancer bioassay in rodents remains the primary testing strategy for in-life screening of compounds that might pose a potential cancer hazard. Yet experimental evidence shows that cancer is often secondary to a biological precursor effect, the mode of action is sometimes not relevant to humans, and key events leading to cancer in rodents from nongenotoxic agents usually occur well before tumorigenesis and at the same or lower doses than those producing tumors. The International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) hypothesized that the signals of importance for human cancer hazard identification can be detected in shorter-term studies. Using the National Toxicology Program (NTP) database, a retrospective analysis was conducted on sixteen chemicals with liver, lung, or kidney tumors in two-year rodent cancer bioassays, and for which short-term data were also available. For nongenotoxic compounds, results showed that cellular changes indicative of a tumorigenic endpoint can be identified for many, but not all, of the chemicals producing tumors in two-year studies after thirteen weeks utilizing conventional endpoints. Additional endpoints are needed to identify some signals not detected with routine evaluation. This effort defined critical questions that should be explored to improve the predictivity of human carcinogenic risk.</p>
]]></description>
<dc:creator><![CDATA[Boobis, A. R., Cohen, S. M., Doerrer, N. G., Galloway, S. M., Haley, P. J., Hard, G. C., Hess, F. G., Macdonald, J. S., Thibault, S., Wolf, D. C., Wright, J.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309343779</dc:identifier>
<dc:title><![CDATA[A Data-Based Assessment of Alternative Strategies for Identification of Potential Human Cancer Hazards]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>732</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>714</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/733?rss=1">
<title><![CDATA[Carcinogenic Effects of MGP-7 and B[a]P on the Hamster Cheek Pouch]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/733?rss=1</link>
<description><![CDATA[
<p>This study was performed to examine the carcinogenic effects of benzo[a]pyrene (B[a]P) and manufactured gas plant (MGP) residues on the hamster cheek pouch (HCP). Syrian hamsters were treated topically with a suspension of 2%, 10%, or 20% B[a]P or 50% or 100% MGP-7 (a mixture of residues from 7 MGP sites) in mineral oil for eight (short-term study) and sixteen, twenty, twenty-eight, and thirty-two weeks (long-term study). The short-term study showed that B[a]P induced p53 protein accumulation, indicative of genotoxic damage, as well as increased cell proliferation, hyperplasia, and inflammation, which is usually associated with promotional activity. In contrast, the MGP-7 presented only marginal p53 accumulation and induction of BrdU incorporation. In the long-term experiments, animals treated with 2% and 10% of B[a]P continued to show p53 protein accumulation as well as hyperplasia and increased cell proliferation and inflammation. By thirty weeks, all the animals treated with B[a]P had a 100% incidence of squamous cell carcinoma (SCC). Animals treated with 50% and 100% MGP-7 showed only weak hyperplasia and a low proliferation rate and accumulation of p53 protein through thirty-two weeks. Benzo[a]pyrene was highly carcinogenic when used at adequate doses. Manufactured gas plant residue, however, was not carcinogenic in this model.</p>
]]></description>
<dc:creator><![CDATA[Brandon, J. L., Conti, C. J., Goldstein, L. S., DiGiovanni, J., Gimenez-Conti, I. B.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309344203</dc:identifier>
<dc:title><![CDATA[Carcinogenic Effects of MGP-7 and B[a]P on the Hamster Cheek Pouch]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>740</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>733</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/741?rss=1">
<title><![CDATA[Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar, a {gamma}-Dominant PPAR {alpha}/{gamma} Agonist]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/741?rss=1</link>
<description><![CDATA[
<p>The carcinogenic potential of naveglitazar, a -dominant peroxisome proliferator-activated receptor (PPAR) / dual agonist, was evaluated in a two-year study in F344 rats (0, 0.3, 1.0, or 3.0 mg/kg, males; 0, 0.1, 0.3, or 1.0 mg/kg, females). Increased mortality in male rats of the high-dose group was related to cardiac-associated lesions, neoplasms, and undetermined causes. Degeneration and hypertrophy of the myocardium occurred with dose-responsive increased incidence and severity. Neoplasms with increased incidence included sarcomas in male rats and urinary bladder neoplasms in female rats. Most sarcomas in male rats occurred in the adipose tissue of the subcutis and were diagnosed as fibrosarcomas, with fewer liposarcomas and other histologic types. Non-neoplastic changes in adipose tissue included expansion of adipose tissue in multiple sites, alterations in cytoplasmic vesicular pattern in brown and white fat, increases in stroma and mesenchymal cells, and fibrosis. The severity of chronic progressive nephropathy was decreased in a dose-responsive manner in males, and hyperplasia and neoplasia of the mammary gland were decreased in incidence in females. The adverse effects of cardiotoxicity and increased incidence of neoplasms occurred with dose-responsive incidence and/or severity, and a no-effect level for these effects was not achieved in this study.</p>
]]></description>
<dc:creator><![CDATA[Long, G. G., Reynolds, V. L., Dochterman, L. W., Ryan, T. E.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309343775</dc:identifier>
<dc:title><![CDATA[Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar, a {gamma}-Dominant PPAR {alpha}/{gamma} Agonist]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>753</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>741</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/754?rss=1">
<title><![CDATA[Longitudinal Studies of Cardiac Troponin-I Concentrations in Serum from Male Sprague Dawley Rats: Baseline Reference Ranges and Effects of Handling and Placebo Dosing on Biological Variability]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/754?rss=1</link>
<description><![CDATA[
<p>Serum cardiac troponin-I has been validated as a biomarker for cardiotoxicity in numerous animal models; however, baseline reference ranges for cTnI concentration in a healthy population of laboratory rats, as well as an investigation of biological cTnI variability in rats with respect to time, handling, and placebo dosing methods, have not been reported. In this study, we used an ultrasensitive cTnI immunoassay to quantify hourly concentrations of cTnI in live rats handled under standard laboratory conditions using 15 &micro;L of serum per determination. The baseline reference range (mean 4.94 pg/mL, range 1&ndash;15 pg/mL, 99% confidence interval [CI]) of cTnI concentration in rats was consistent with previously reported reference ranges for cTnI in humans (1&ndash;12 pg/mL) and with preliminary studies in dogs (1&ndash;4 pg/mL) and monkeys (4&ndash;5 pg/mL) using the same cTnI assay method. In addition, cTnI concentrations in individual rat serum samples show minimal biological variability over a twenty-four-hour interval when compared to a meaningful reference change value of 193% to 206%. Furthermore, measurements of cTnI concentration were consistent within the reference limits in individual rats over long periods and under three different standard laboratory handling conditions. Thus, using this new method, rats can be followed longitudinally at hourly intervals, and a doubling of cTnI concentration would be significant above biological variability. This is a new paradigm for preclinical testing, which allows transient changes in cTnI concentration to be accurately quantified. This understanding of baseline and biological variability in rats will be fundamental for designing and analyzing future studies that assess potential cardiotoxicity in drug development.</p>
]]></description>
<dc:creator><![CDATA[Schultze, A. E., Carpenter, K. H., Wians, F. H., Agee, S. J., Minyard, J., Lu, Q. A., Todd, J., Konrad, R. J.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309343777</dc:identifier>
<dc:title><![CDATA[Longitudinal Studies of Cardiac Troponin-I Concentrations in Serum from Male Sprague Dawley Rats: Baseline Reference Ranges and Effects of Handling and Placebo Dosing on Biological Variability]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>760</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>754</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/761?rss=1">
<title><![CDATA[Mechanistic Study on Hepatocarcinogenesis of Piperonyl Butoxide in Mice]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/761?rss=1</link>
<description><![CDATA[
<p>To clarify the mechanism of piperonyl butoxide (PBO)-induced hepatocarcinogenesis in mice, male mice were subjected to a two-thirds partial hepatectomy, N-diethylnitrosamine (DEN) initiation, and a diet containing 0.6% PBO for eight weeks. The incidence of -glutamyl transpeptidase (GGT)-positive foci and PCNA-positive cells was significantly increased in the DEN + PBO group compared with the DEN-alone group. Real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis showed up-regulation of genes related to metabolism, such as cytochrome P450 1A1 and 2B10, and metabolic stress, such as <I>Por, Nqo1, Nrf2, abcc3</I>, and <I>abcc4</I>. Early responsive genes downstream of mitogen-activated protein kinase (MAPK), such as <I>c-fos, c-jun, c-myc</I>, and activating transcription factor 3 (<I>ATF3</I>), were also up-regulated in this group. Positive immunohistochemical staining for ATF3 was diffusely observed in nonproliferating hepatocytes of the DEN + PBO group, but altered foci were negative or weakly positive for ATF3. The nuclei of hepatocytes within ATF3-negative foci were positive for cyclin D. Thus PBO can induce oxidative stress, activate the MAPK pathway, and increase ATF3 transcript levels in hepatocytes outside the altered foci during the early stage of PBO-induced hepatocarcinogenesis in mice.</p>
]]></description>
<dc:creator><![CDATA[Kawai, M., Saegusa, Y., Jin, M., Dewa, Y., Nishimura, J., Harada, T., Shibutani, M., Mitsumori, K.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309344087</dc:identifier>
<dc:title><![CDATA[Mechanistic Study on Hepatocarcinogenesis of Piperonyl Butoxide in Mice]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>769</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>761</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/770?rss=1">
<title><![CDATA[Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the Kidneys]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/770?rss=1</link>
<description><![CDATA[
<p>In canine leishmaniosis (CanL), kidneys are affected in virtually all dogs. Treatment of CanL is limited in Europe to meglumine antimoniate and miltefosine. This study evaluated the pharmacological, toxicological, and pathological effects of both drugs in healthy beagle dogs. Four male and four female dogs were divided into two groups. The animals in Group 1 were administered an oral solution of 2% of miltefosine at 2 mg/kg b.w. once a day, for twenty-eight days. The animals in Group 2 were administered a preparation of meglumine antimoniate at 100 mg/kg b.w. subcutaneously once a day for twenty-eight days. After treatment, all dogs were followed-up for a further twenty-eight days. Dogs were observed daily and clinically examined ten times throughout the study. On days -1 and 55 a renal biopsy was performed on all dogs and analyzed by light microscopy, immunofluorescence, and electron microscopy. All the examinations failed to demonstrate any lesions in the miltefosine-treated dogs. Conversely, all the meglumine antimoniate&ndash;treated dogs demonstrated severe tubular damage, characterized by tubular cell necrosis and apoptosis. In conclusion, although no clinical signs of renal disease were evident, the use of meglumine antimoniate in the pharmacological treatment approach of CanL-affected dogs should be carefully considered.</p>
]]></description>
<dc:creator><![CDATA[Bianciardi, P., Brovida, C., Valente, M., Aresu, L., Cavicchioli, L., Vischer, C., Giroud, L., Castagnaro, M.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309344088</dc:identifier>
<dc:title><![CDATA[Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the Kidneys]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>775</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>770</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/776?rss=1">
<title><![CDATA[Kainic Acid-induced F-344 Rat model of Mesial Temporal Lobe Epilepsy: Gene Expression and Canonical Pathways]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/776?rss=1</link>
<description><![CDATA[
<p>Mesial temporal lobe epilepsy (MTLE) is a severe neurological condition of unknown pathogenesis for which several animal models have been developed. To obtain a better understanding of the underlying molecular mechanisms and identify potential biomarkers of lesion progression, we used a rat kainic acid (KA) treatment model of MTLE coupled with global gene expression analysis to examine temporal (four hours, days 3, 14, or 28) gene regulation relative to hippocampal histopathological changes. The authors recommend reviewing the companion histopathology paper (<cross-ref type="bib" refid="b62-0370776">Sharma et al. 2008</cross-ref>) to get a better understanding of the work presented here. Analysis of filtered gene expression data using Ingenuity Pathways Analysis (Ingenuity Systems, <inter-ref locator="http://www.ingenuity.com" locator-type="url">http://www.ingenuity.com</inter-ref>) revealed that a number of genes pertaining to neuronal plasticity (RhoA, Rac1, Cdc42, BDNF, and Trk), neurodegeneration (Caspase3, Calpain 1, Bax, a Cytochrome c, and Smac/Diablo), and inflammation/immune-response pathways (TNF-, CCL2, Cox2) were modulated in a temporal fashion after KA treatment. Expression changes for selected genes known to have a role in neuronal plasticity were subsequently validated by quantitative polymerase chain reaction (qPCR). Notably, canonical pathway analysis revealed that a number of genes within the axon guidance signaling canonical pathway were up-regulated from Days 3 to 28, which correlated with aberrant mossy fiber (MF) sprouting observed histologically beginning at Day 6. Importantly, analysis of the gene expression data also identified potential biomarkers for monitoring neurodegeneration (Cox2) and neuronal/synaptic plasticity (Kalrn).</p>
]]></description>
<dc:creator><![CDATA[Sharma, A. K., Searfoss, G. H., Reams, R. Y., Jordan, W. H., Snyder, P. W., Chiang, A. Y., Jolly, R. A., Ryan, T. P.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309344202</dc:identifier>
<dc:title><![CDATA[Kainic Acid-induced F-344 Rat model of Mesial Temporal Lobe Epilepsy: Gene Expression and Canonical Pathways]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>789</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>776</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/790?rss=1">
<title><![CDATA[Effects of the Antifungal Agent Itraconazole on Proliferative Changes of the Forestomach Mucosa in Alloxan-induced Diabetic Rats]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/790?rss=1</link>
<description><![CDATA[
<p>Alloxan-induced diabetic rats frequently exhibit proliferative lesions of squamous hyperplasia accompanied by chronic inflammation and <I>Candida albicans</I> infection in the forestomach, and some lesions progress to squamous cell carcinoma (SCC). <I>Candida</I> infection causes not only hyperplastic changes with inflammation but might also lead to SCC in human oral mucosa. Thus, the present study was conducted to examine the effects of the antifungal agent itraconazole (ITCZ) on proliferative and inflammatory changes of the forestomach in alloxan-induced diabetic WBN/Kob rats. Diabetes was induced by alloxan at fifteen weeks of age. Rats were allocated to three groups at forty-five weeks of age and were given ITCZ by gavage 0 (vehicle control), 5, and 10 mg/kg/day for four weeks, and they were sacrificed at the sixty-fifth week of age. Mucosal hyperplastic changes were consistently accompanied by inflammation and <I>Candida</I> infections in the 0 mg/kg group. These lesions were reduced by ITCZ (0 mg/kg; 100%, 5 mg/kg; 53.5%, 10 mg/kg; 61.5%). Squamous cell carcinoma was detected in three rats from the 0 mg/kg, but only one rat from the 10 mg/kg dose groups in this study. Itraconazole reduced the degree of mucosal hyperplasia, inflammatory changes, and <I>Candida</I> infection. Therefore, <I>C. albicans</I> infection was an important factor in pathogenesis of mucosal proliferation and inflammation.</p>
]]></description>
<dc:creator><![CDATA[Sano, T., Ozaki, K., Kodama, Y., Matsuura, T., Narama, I.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309344204</dc:identifier>
<dc:title><![CDATA[Effects of the Antifungal Agent Itraconazole on Proliferative Changes of the Forestomach Mucosa in Alloxan-induced Diabetic Rats]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>798</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>790</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/799?rss=1">
<title><![CDATA[Systemic Inflammatory Response Syndrome in Nonhuman Primates Culminating in Multiple Organ Failure, Acute Lung Injury, and Disseminated Intravascular Coagulation]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/799?rss=1</link>
<description><![CDATA[
<p>The systemic inflammatory response syndrome (SIRS) is a clinicopathological manifestation of overexuberant acute-phase inflammation caused by infectious or noninfectious etiologies. The systemic release of pro-inflammatory cytokines, chemokines, and lipid and vasoactive mediators induces endothelial damage and microvascular thrombosis, potentially culminating in disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and multiple organ dysfunction (MOD) or failure (MOF). We present five cases in the pig-tailed macaque and olive baboon where SIRS resulted in MOF, ARDS, DIC, and the Waterhouse-Friderichsen syndrome; each with gross and histological elements manifested as edema, deposition of fibrin, hemorrhage, and thrombosis. In the described cases, SIRS was the end-common pathway for multiple risk factors that parallel those documented in humans: major surgery, obstetric complications, and infection. The diagnosis of SIRS should be considered when evaluating nonhuman primate (NHP) cases of MOF manifesting with histological evidence of vascular leakage. Experimental manipulation of NHP models may be complicated by SIRS and accompanying rapid clinical decompensation. Such adverse events may compromise toxicological studies and should be avoided when possible.</p>
]]></description>
<dc:creator><![CDATA[Hukkanen, R. R., Liggitt, H. D., Murnane, R. D., Frevert, C. W.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309343778</dc:identifier>
<dc:title><![CDATA[Systemic Inflammatory Response Syndrome in Nonhuman Primates Culminating in Multiple Organ Failure, Acute Lung Injury, and Disseminated Intravascular Coagulation]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>804</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>799</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/805?rss=1">
<title><![CDATA[Activation of Calcitonin Gene-Related Peptide Receptor during Ozone Inhalation Contributes to Airway Epithelial Injury and Repair]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/805?rss=1</link>
<description><![CDATA[
<p>The authors investigated the importance of the neuropeptide, calcitonin gene-related peptide (CGRP), in epithelial injury, repair, and neutrophil emigration after ozone exposure. Wistar rats were administered either a CGRP-receptor antagonist (CGRP<SUB>8&ndash;37</SUB>) or saline and exposed to 8 hours of 1-ppm ozone or filtered air with an 8-hour postexposure period. Immediately after exposure, ethidium homodimer was instilled into lungs as a marker of necrotic airway epithelial cells. After fixation, airway dissected lung lobes were stained for 5'-bromo-2'-deoxyuridine, a marker of epithelial proliferation. Positive epithelial cells were quantified in specific airway generations. Rats treated with CGRP<SUB>8&ndash;37</SUB> had significantly reduced epithelial injury in terminal bronchioles and reduced epithelial proliferation in proximal airways and terminal bronchioles. Bronchoalveolar lavage and sections of terminal bronchioles showed no significant difference in the number of neutrophils emigrating into airways in CGRP<SUB>8&ndash;37</SUB>-treated rats. The airway epithelial cell line, HBE-1, showed no difference in the number of oxidant stress positive cells during exposure to hydrogen peroxide and a range of CGRP<SUB>8&ndash;37</SUB> doses, demonstrating no antioxidant effect of CGRP<SUB>8&ndash;37</SUB>. We conclude that activation of CGRP receptors during ozone inhalation contributes to airway epithelial injury and subsequent epithelial proliferation, a critical component of repair, but does not influence neutrophil emigration into airways.</p>
]]></description>
<dc:creator><![CDATA[Oslund, K. L., Hyde, D. M., Putney, L. F., Alfaro, M. F., Walby, W. F., Tyler, N. K., Schelegle, E. S.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309345691</dc:identifier>
<dc:title><![CDATA[Activation of Calcitonin Gene-Related Peptide Receptor during Ozone Inhalation Contributes to Airway Epithelial Injury and Repair]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>813</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>805</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/814?rss=1">
<title><![CDATA[Spontaneous Cardiomyopathy in Cynomolgus Monkeys (Macaca Fascicularis)]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/814?rss=1</link>
<description><![CDATA[
<p>A previously undescribed spontaneous cardiomyopathy was identified by routine light microscopic examination of the heart from four clinically healthy purpose-bred cynomolgus monkeys that ranged from four to nine years of age and included 2 males and 2 females. Special stains of Sirius red, Masson&rsquo;s trichrome, and Mallory&rsquo;s phosphotungstic acid hematoxylin (PTAH); and immunohistochemistry using anti-CD68, troponin-I, and desmin antibodies were used to facilitate lesion characterization and assess cardiomyocyte viability. Microscopically, the apical to mid-ventricular myocardium to subendocardium had foci of cardiomyocyte disarray with cytoplasmic pallor to stippling and karyomegaly, vacuolization of the perimyseal connective tissue, a meshwork of fibrous tissue that concentrated around medium-sized blood vessels and dissected between or less often replaced affected cardiomyocytes; and a minimal, predominantly macrophage infiltrate. The disrupted cardiomyocytes were immunoreactive to desmin and troponin-I antibodies and had a normal cross-striation pattern by PTAH, indicating the chronic cardiomyopathy was not associated with active cardiomyocyte damage. The consistent distribution and morphology of the cardiomyopathy suggested a common etiology and pathogenesis. The features were reminiscent of chronic catecholamine-induced experimental cardiomyopathy and stress cardiomyopathy in monkeys and humans, respectively. This report documents another spontaneous heart lesion in clinically healthy monkeys for consideration during interpretation of toxicology studies.</p>
]]></description>
<dc:creator><![CDATA[Zabka, T. S., Irwin, M., Albassam, M. A.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309345692</dc:identifier>
<dc:title><![CDATA[Spontaneous Cardiomyopathy in Cynomolgus Monkeys (Macaca Fascicularis)]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>818</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>814</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/content/abstract/37/6/819?rss=1">
<title><![CDATA[Intralobar Nephroblastematosis in a Nine-week-old Wistar Rat]]></title>
<link>http://tpx.sagepub.com/cgi/content/abstract/37/6/819?rss=1</link>
<description><![CDATA[
<p>Intralobar nephroblastematosis (ILNB) is a precursor lesion to the development of nephroblastoma (NB) in rats. Unilateral ILNB was observed in the kidney of a nine-week-old female Wistar rat (Crl:WI) from a short-term toxicity study. Clinical pathology and urinalysis did not reveal altered renal function. This microscopic, unencapsulated lesion consisted of basophilic sheets of blastemal cells that did not include a prominent mesenchymal component. These cells expanded in the interstitium, which trapped and compressed few normal renal tubules. The blastemal cells moderately differentiated to form rosettes, primitive tubules, and a glomeruloid body. Multifocally, the lumen of primitive tubules contained eosinophilic secretions with basophilic material in the center. The diagnostic criteria used were compared and differentiated with renal dysplasia, nephrogenic rest, NB in rats, and with that of the identical lesion in children.</p>
]]></description>
<dc:creator><![CDATA[Kalaiselvan, P., Mathur, K.Y., Pande, V.V., Madheswaran, R., Bhelonde, J.J., Shelar, P.D., Udupa, V., Shingatgeri, V.M.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309343776</dc:identifier>
<dc:title><![CDATA[Intralobar Nephroblastematosis in a Nine-week-old Wistar Rat]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>825</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>819</prism:startingPage>
<prism:section>Case Report</prism:section>
</item>

<item rdf:about="http://tpx.sagepub.com/cgi/reprint/37/6/826?rss=1">
<title><![CDATA[Regulatory Forum for Toxicologic Pathology: A Two-year Update]]></title>
<link>http://tpx.sagepub.com/cgi/reprint/37/6/826?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Schafer, K., Francke-Carroll, S., Hutto, D., Neef, N., Silverman, L., Vahle, J., Whitney, K.]]></dc:creator>
<dc:date>Tue, 22 Sep 2009 16:58:29 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0192623309346747</dc:identifier>
<dc:title><![CDATA[Regulatory Forum for Toxicologic Pathology: A Two-year Update]]></dc:title>
<dc:publisher>Society of Toxicologic Pathology</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>37</prism:volume>
<prism:endingPage>826</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>826</prism:startingPage>
<prism:section>Regulatory Forum</prism:section>
</item>

</rdf:RDF>